A
LIVE

Serial Number

97657931

Owner

AMGEN INC.

Attorney

Elsa D. Lemoine

First Use Date

Oct 1, 2023

Filing Date

Nov 1, 2022

Add to watchlist:

No watchlists yet
View on USPTO

A Trademark

Serial Number: 97657931 • Registration: 7538562

A is a trademark filed by AMGEN INC. on November 1, 2022. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

AMGEN INC. (819 trademarks)

THOUSAND OAKS, CA 91320

Entity Type: 03

Trademark Details

Filing Date

November 1, 2022

Registration Date

October 15, 2024

First Use Anywhere

October 1, 2023

First Use in Commerce

October 1, 2023

Published for Opposition

October 3, 2023

Goods & Services

Providing medical information and patient support services, namely, providing medical information in the fields of pharmaceuticals and the treatment of various illnesses, disorders and maladies

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 25, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 25, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 25, 2025 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 15, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 15, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 11, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 11, 2024 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jun 5, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 4, 2024 AITU
USE AMENDMENT FILED
May 2, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
May 2, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 28, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 3, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 3, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 13, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 30, 2023 CNSA
ASSIGNED TO EXAMINER
Aug 15, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 19, 2022 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 18, 2022 NWOS
NEW APPLICATION ENTERED
Nov 4, 2022 NWAP